Caplight Directory>Investors>Eisai Innovation>Eisai-innovation


Eisai Innovation

Eisai Innovation

Cambridge, Massachusettseisaiinnovation.com

Overview

Eisai Innovation, Inc. is an investment entity formed to add cutting-edge technologies, drug modalities, and digital healthcare solutions into the Eisai network . Eisai Innovation identifies opportunities for the Eisai Group to invest in venture businesses that align with Eisai's goal of contributing to patients, focusing on cutting-edge drug discovery platforms, and new modalities, as well as leading biotechnology in focus areas of neurology, oncology, and global health .

Year Founded

2019

Portfolio Companies

8

Investments

CompanyDateStageLead
Vivacta Biotechnology (Shanghai) Co., Ltd.Apr 2026Series ACo-investor
Excalipoint TherapeuticsMar 2026SeedCo-investor
Tacit TherapeuticsMar 2026Series ACo-investor
Sift BiosciencesFeb 2026Pre SeedCo-investor
Sift BiosciencesFeb 2026Pre SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersCambridge, Massachusetts
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.